Article
Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro.
Stem cell research & therapy - 17 Apr 2017
Redondo-Castro Elena, Cunningham Catriona, Miller Jonjo, Martuscelli Licia, Aoulad-Ali Sarah, Rothwell Nancy J, Kielty Cay M, Allan Stuart M, Pinteaux Emmanuel
Abstract excerpt
BACKGROUND: Inflammation is a key contributor to central nervous system (CNS) injury such as stroke, and is a major target for therapeutic intervention. Effective treatments for CNS injuries are limited and applicable to only a minority of patients. Stem cell-based therapies are increasingly considered for the treatment of CNS disease, because they can be used as in-situ regulators of inflammation, and improve...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
